speb/financial-data huggingface dataset:
FGNXP cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 1810000.00
FGNXP income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 268000.00
FGNXP income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2512000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Share Issued: 254323.00
FGNXP cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -131000.00
FGNXP income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
FGNXP cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 175000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 64153000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 41788000.00
FGNXP income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
FGNXP income_statement (quarterly, 2025-03-31) — Tax Provision: -68000.00
FGNXP income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.01
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Assets: 100309000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 64387000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Debt: 3418000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 64153000.00
FGNXP income_statement (quarterly, 2025-03-31) — Total Expenses: 2512000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 36156000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 52199000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3888000.00
FGNXP income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -2274000.00
FGNXP income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 4000.00
FGNXP income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
FGNXP income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
FGNXP cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Work In Process: 3000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Working Capital: 15842000.00
FGNXP income_statement (quarterly, 2025-03-31) — Write Off: 0.00
FGNXP income_statement (quarterly, 2025-06-30) — +Total Revenue: 9085000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4521000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 51034000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
FGNXP cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4437000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1269000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Capital Stock: 22394000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 11076000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 11076000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -448000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1111000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 1919000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1074000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Financing Activities: 142000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Investing Activities: 5643000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: -122000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -914000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -51000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 13000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1266000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Change In Receivables: -850000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -605000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -850000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Changes In Cash: 5397000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Common Stock: 29000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 46982000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Current Debt: 1984000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1984000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 143000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Deferred Tax: 143000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 303000.00
FGNXP income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 5025000.00
FGNXP income_statement (quarterly, 2025-06-30) — EBIT: 5280000.00
FGNXP income_statement (quarterly, 2025-06-30) — EBITDA: 5583000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -7708000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 10000.00
FGNXP cash_flow (quarterly, 2025-06-30) — End Cash Position: 11076000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -969000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1211000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 292000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1325000.00
FGNXP income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2616000.00
FGNXP income_statement (quarterly, 2025-06-30) — Interest Expense: 22000.00
FGNXP income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 22000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Invested Capital: 49169000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 7562000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 4666000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1269000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 203000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1472000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -145000.00
FGNXP income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
FGNXP cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income: 5472000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 5025000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 5048000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 424000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5472000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5048000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 4880000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5472000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Interest Income: -22000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 1820000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -348000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -145000.00
FGNXP income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -22000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Net PPE: 3931000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -61000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 69347000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2426000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2426000.00
FGNXP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 5596000.00
FGNXP income_statement (quarterly, 2025-06-30) — Normalized Income: 5060480.79
FGNXP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1196000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -7411000.00
FGNXP income_statement (quarterly, 2025-06-30) — Operating Revenue: 9085000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 256927.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1984000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1325000.00
FGNXP income_statement (quarterly, 2025-06-30) — Other Gand A: 2616000.00
FGNXP income_statement (quarterly, 2025-06-30) — Other Income Expense: 5251000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 24000.00
FGNXP income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 4271000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 6459000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 894580.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 22365000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -448000.00
FGNXP income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 447000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 22365000.00
FGNXP income_statement (quarterly, 2025-06-30) — Pretax Income: 5258000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 15000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Receivables: 4521000.00
FGNXP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 303000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -348000.00
FGNXP income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 8000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -5406000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
FGNXP cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1805000.00
FGNXP income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 348000.00
FGNXP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2964000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Share Issued: 256927.00
FGNXP cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -61000.00
FGNXP income_statement (quarterly, 2025-06-30) — Special Income Charges: -13000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 250000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 69347000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 46982000.00
FGNXP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -519.21
FGNXP income_statement (quarterly, 2025-06-30) — Tax Provision: 210000.00
FGNXP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.04
FGNXP balance_sheet (quarterly, 2025-06-30) — Total Assets: 92862000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 69550000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Total Debt: 3456000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 69347000.00
FGNXP income_statement (quarterly, 2025-06-30) — Total Expenses: 3827000.00
FGNXP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 23515000.00
FGNXP income_statement (quarterly, 2025-06-30) — Total Unusual Items: -13000.00
FGNXP income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -13000.00
FGNXP cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 1295000.00
FGNXP income_statement (quarterly, 2025-06-30) — Write Off: 5000.00
FGNXP income_statement (quarterly, 2025-09-30) — +Operating Expense: 10702000.00
FGNXP income_statement (quarterly, 2025-09-30) — +Total Revenue: 892000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2483000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 215671000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 10408000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 11076000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 22432000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7495000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 7495000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -446000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 164057000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -165342000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -679000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Financing Activities: -408000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Investing Activities: -37000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: 47000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 66000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 102000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -170000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2358000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3224000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2362000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Common Stock: 67000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 208656000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Current Assets: 17903000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Current Debt: 1918000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1918000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 11545000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -709000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Deferred Tax: -709000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: -150000.00
FGNXP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3838000.00
FGNXP income_statement (quarterly, 2025-09-30) — EBIT: -9810000.00
FGNXP income_statement (quarterly, 2025-09-30) — EBITDA: -9810000.00
FGNXP income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -7289000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 9911000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 13000.00
FGNXP cash_flow (quarterly, 2025-09-30) — End Cash Position: 7495000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 163649000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -617000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -578000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
FGNXP income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -21000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2162000.00
FGNXP income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10702000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 210574000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -165379000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 0.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 12804000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
FGNXP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 287000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 12804000.00
FGNXP income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -171720000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income: -3391000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3838000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3137000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -254000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3391000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3137000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3635000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3391000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Interest Income: 13000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 6474000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 260000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 287000.00
FGNXP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 13000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3842000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -111000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Net PPE: 2247000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
FGNXP cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -27000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 231021000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1712000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1712000.00
FGNXP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -9784000.00
FGNXP income_statement (quarterly, 2025-09-30) — Normalized Income: -3116460.00
FGNXP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -632000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 9354000.00
FGNXP income_statement (quarterly, 2025-09-30) — Operating Income: -9810000.00
FGNXP income_statement (quarterly, 2025-09-30) — Operating Revenue: 892000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7966837.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1918000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 7144000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2162000.00
FGNXP income_statement (quarterly, 2025-09-30) — Other Gand A: 3352000.00
FGNXP income_statement (quarterly, 2025-09-30) — Other Income Expense: 6763000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -740000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 211783000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 459000.00
FGNXP income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 14078000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Payables: 2483000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2483000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 894580.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 22365000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -446000.00
FGNXP income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 447000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 22365000.00
FGNXP income_statement (quarterly, 2025-09-30) — Pretax Income: -3034000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -625000.00
FGNXP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: -150000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 260000.00
FGNXP income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 5000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -9244000.00
FGNXP income_statement (quarterly, 2025-09-30) — Salaries And Wages: 7350000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
FGNXP cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 7099000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
FGNXP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10702000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Share Issued: 7966837.00
FGNXP cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -27000.00
FGNXP income_statement (quarterly, 2025-09-30) — Special Income Charges: -5000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7350000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 231021000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 208656000.00
FGNXP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -5460.00
FGNXP income_statement (quarterly, 2025-09-30) — Tax Provision: 103000.00
FGNXP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Assets: 244737000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 231021000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Debt: 1918000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 231021000.00
FGNXP income_statement (quarterly, 2025-09-30) — Total Expenses: 10702000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 13716000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 226834000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2171000.00
FGNXP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 4247000.00
FGNXP income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -13000.00
FGNXP income_statement (quarterly, 2025-09-30) — Total Unusual Items: -26000.00
FGNXP income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -26000.00
FGNXP cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -15373000.00
FGNXP balance_sheet (quarterly, 2025-09-30) — Working Capital: 6358000.00
FGNXP income_statement (quarterly, 2025-09-30) — Write Off: 0.00
FGNXP income_statement (annual, 2025-12-31) — +Operating Expense: 22266000.00
FGNXP income_statement (quarterly, 2025-12-31) — +Operating Expense: 7250000.00
FGNXP income_statement (annual, 2025-12-31) — +Total Revenue: 2413000.00
FGNXP income_statement (quarterly, 2025-12-31) — +Total Revenue: 1076000.00
FGNXP balance_sheet (annual, 2025-12-31) — Accounts Payable: 5338000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5338000.00
FGNXP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 216682000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 216682000.00
FGNXP cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
FGNXP balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 13883000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 13883000.00
FGNXP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6562000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 7495000.00
FGNXP balance_sheet (annual, 2025-12-31) — Capital Stock: 22293000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 22293000.00
FGNXP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 13395000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13395000.00
FGNXP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13395000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13395000.00
FGNXP cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1788000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -447000.00
FGNXP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 136022000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -26346000.00
FGNXP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -128147000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 33743000.00
FGNXP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6663000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2536000.00
FGNXP cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: -408000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 5592000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 413000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 1037000.00
FGNXP cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 316000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 1040000.00
FGNXP cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -148000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -74000.00
FGNXP cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 5772000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2669000.00
FGNXP cash_flow (annual, 2025-12-31) — Change In Working Capital: 5940000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 3635000.00
FGNXP cash_flow (annual, 2025-12-31) — Changes In Cash: 6809000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Changes In Cash: 5898000.00
FGNXP balance_sheet (annual, 2025-12-31) — Common Stock: 70000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Common Stock: 70000.00
FGNXP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 121268000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 121268000.00
FGNXP cash_flow (annual, 2025-12-31) — Common Stock Issuance: 168621000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 536000.00
FGNXP cash_flow (annual, 2025-12-31) — Common Stock Payments: -26133000.00
FGNXP balance_sheet (annual, 2025-12-31) — Current Assets: 27278000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Current Assets: 27278000.00
FGNXP balance_sheet (annual, 2025-12-31) — Current Debt: 1923000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Current Debt: 1923000.00
FGNXP balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1923000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1923000.00
FGNXP balance_sheet (annual, 2025-12-31) — Current Liabilities: 16688000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 16688000.00
FGNXP cash_flow (annual, 2025-12-31) — Deferred Income Tax: -2059000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1342000.00
FGNXP cash_flow (annual, 2025-12-31) — Deferred Tax: -2059000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1342000.00
FGNXP cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 304000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 73000.00
FGNXP cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 304000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 73000.00
FGNXP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -68514000.00
FGNXP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -59498000.00
FGNXP income_statement (annual, 2025-12-31) — EBIT: -67575000.00
FGNXP income_statement (quarterly, 2025-12-31) — EBIT: -53896000.00
FGNXP income_statement (annual, 2025-12-31) — EBITDA: -67271000.00
FGNXP income_statement (quarterly, 2025-12-31) — EBITDA: -53823000.00
FGNXP income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -5503000.00
FGNXP income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 1965000.00
FGNXP cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 7476000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -1964000.00
FGNXP cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 24000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 2000.00
FGNXP cash_flow (annual, 2025-12-31) — End Cash Position: 13395000.00
FGNXP cash_flow (quarterly, 2025-12-31) — End Cash Position: 13395000.00
FGNXP cash_flow (annual, 2025-12-31) — Financing Cash Flow: 135614000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -26346000.00
FGNXP cash_flow (annual, 2025-12-31) — Free Cash Flow: -6250000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1499000.00
FGNXP cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 5815000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 5794000.00
FGNXP cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -1056000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 5000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
FGNXP income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -5815000.00
FGNXP income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1936000.00
FGNXP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1957000.00
FGNXP balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -608000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -608000.00
FGNXP income_statement (annual, 2025-12-31) — General And Administrative Expense: 22266000.00
FGNXP income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7250000.00
FGNXP income_statement (annual, 2025-12-31) — Interest Expense: 132000.00
FGNXP income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 132000.00
FGNXP balance_sheet (annual, 2025-12-31) — Invested Capital: 123191000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 123191000.00
FGNXP cash_flow (annual, 2025-12-31) — Investing Cash Flow: -122555000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 33743000.00
FGNXP balance_sheet (annual, 2025-12-31) — Investments And Advances: 14670000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 14670000.00
FGNXP cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 168621000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 536000.00
FGNXP cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
FGNXP balance_sheet (annual, 2025-12-31) — Line Of Credit: 0.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
FGNXP balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 14670000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 14670000.00
FGNXP balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
FGNXP income_statement (annual, 2025-12-31) — Minority Interests: 0.00
FGNXP income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -137977000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 33743000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 142488000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -25597000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income: -66742000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income: -59067000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -68514000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -59498000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -67634000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -60250000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 892000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 1183000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -66742000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -59067000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -67634000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -60250000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -67634000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -60250000.00
FGNXP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -66742000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -59067000.00
FGNXP income_statement (annual, 2025-12-31) — Net Interest Income: -132000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Interest Income: -92000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 9827000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -247000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -28000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
FGNXP income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -132000.00
FGNXP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -92000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -4304000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -147000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 3000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
FGNXP balance_sheet (annual, 2025-12-31) — Net PPE: 2208000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Net PPE: 2208000.00
FGNXP cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: -127000.00
FGNXP cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -247000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -28000.00
FGNXP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 143491000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 143491000.00
FGNXP balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 365000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 365000.00
FGNXP balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 365000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 365000.00
FGNXP income_statement (annual, 2025-12-31) — Normalized EBITDA: -63379000.00
FGNXP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -49961000.00
FGNXP income_statement (annual, 2025-12-31) — Normalized Income: -63745892.00
FGNXP income_statement (quarterly, 2025-12-31) — Normalized Income: -56408276.65
FGNXP cash_flow (annual, 2025-12-31) — Operating Cash Flow: -6250000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1499000.00
FGNXP cash_flow (annual, 2025-12-31) — Operating Gains Losses: 12240000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 3830000.00
FGNXP income_statement (annual, 2025-12-31) — Operating Income: -19853000.00
FGNXP income_statement (quarterly, 2025-12-31) — Operating Income: -6174000.00
FGNXP income_statement (annual, 2025-12-31) — Operating Revenue: 2413000.00
FGNXP income_statement (quarterly, 2025-12-31) — Operating Revenue: 1076000.00
FGNXP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 7080747.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 7080747.00
FGNXP balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1923000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1923000.00
FGNXP balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 9427000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 9427000.00
FGNXP balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -608000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -608000.00
FGNXP income_statement (annual, 2025-12-31) — Other Gand A: 14506000.00
FGNXP income_statement (quarterly, 2025-12-31) — Other Gand A: 7265000.00
FGNXP income_statement (annual, 2025-12-31) — Other Income Expense: -47722000.00
FGNXP income_statement (quarterly, 2025-12-31) — Other Income Expense: -54302000.00
FGNXP cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1543000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -874000.00
FGNXP balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 119688000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 119688000.00
FGNXP balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 3300000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 3300000.00
FGNXP income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -38327000.00
FGNXP income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -52405000.00
FGNXP balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
FGNXP income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: -16000.00
FGNXP balance_sheet (annual, 2025-12-31) — Payables: 5338000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Payables: 5338000.00
FGNXP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 5338000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5338000.00
FGNXP balance_sheet (annual, 2025-12-31) — Preferred Stock: 22223000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 22223000.00
FGNXP cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -1788000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -447000.00
FGNXP income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 1788000.00
FGNXP income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 447000.00
FGNXP balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 22223000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 22223000.00
FGNXP cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -127000.00
FGNXP income_statement (annual, 2025-12-31) — Pretax Income: -67707000.00
FGNXP income_statement (quarterly, 2025-12-31) — Pretax Income: -60568000.00
FGNXP cash_flow (annual, 2025-12-31) — Purchase Of Business: -137977000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 33743000.00
FGNXP cash_flow (annual, 2025-12-31) — Purchase Of Investment: -887000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
FGNXP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 304000.00
FGNXP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 73000.00
FGNXP cash_flow (annual, 2025-12-31) — Repayment Of Debt: -247000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -28000.00
FGNXP cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -26260000.00
FGNXP income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 8000.00
FGNXP income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 4000.00
FGNXP balance_sheet (annual, 2025-12-31) — Retained Earnings: -68743000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -68743000.00
FGNXP income_statement (annual, 2025-12-31) — Salaries And Wages: 7760000.00
FGNXP income_statement (quarterly, 2025-12-31) — Salaries And Wages: -15000.00
FGNXP cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Sale Of Investment: 10714000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
FGNXP cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
FGNXP cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
FGNXP income_statement (annual, 2025-12-31) — Selling General And Administration: 22266000.00
FGNXP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7250000.00
FGNXP balance_sheet (annual, 2025-12-31) — Share Issued: 8698995.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Share Issued: 8698995.00
FGNXP cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -247000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -28000.00
FGNXP income_statement (annual, 2025-12-31) — Special Income Charges: -5828000.00
FGNXP income_statement (quarterly, 2025-12-31) — Special Income Charges: -5819000.00
FGNXP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 7762000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -13000.00
FGNXP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 143491000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 143491000.00
FGNXP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 121268000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 121268000.00
FGNXP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3892.00
FGNXP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -20276.65
FGNXP income_statement (annual, 2025-12-31) — Tax Provision: -73000.00
FGNXP income_statement (quarterly, 2025-12-31) — Tax Provision: -318000.00
FGNXP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
FGNXP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.01
FGNXP balance_sheet (annual, 2025-12-31) — Total Assets: 163844000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Assets: 163844000.00
FGNXP balance_sheet (annual, 2025-12-31) — Total Capitalization: 143491000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 143491000.00
FGNXP balance_sheet (annual, 2025-12-31) — Total Debt: 1923000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Debt: 1923000.00
FGNXP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 143491000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 143491000.00
FGNXP income_statement (annual, 2025-12-31) — Total Expenses: 22266000.00
FGNXP income_statement (quarterly, 2025-12-31) — Total Expenses: 7250000.00
FGNXP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 20353000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 20353000.00
FGNXP balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 136566000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 136566000.00
FGNXP balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3665000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3665000.00
FGNXP income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -64000000.00
FGNXP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -64373000.00
FGNXP income_statement (annual, 2025-12-31) — Total Unusual Items: -3892000.00
FGNXP income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3862000.00
FGNXP income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3892000.00
FGNXP income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3862000.00
FGNXP balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 1618248.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1618248.00
FGNXP balance_sheet (annual, 2025-12-31) — Treasury Stock: 26133000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 26133000.00
FGNXP cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 38327000.00
FGNXP cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 52405000.00
FGNXP balance_sheet (annual, 2025-12-31) — Working Capital: 10590000.00
FGNXP balance_sheet (quarterly, 2025-12-31) — Working Capital: 10590000.00
FGNXP income_statement (annual, 2025-12-31) — Write Off: 5000.00
FGNXP income_statement (quarterly, 2025-12-31) — Write Off: 0.00
FGNXP income_statement (quarterly, 2026-03-31) — +Operating Expense: 3797000.00
FGNXP income_statement (quarterly, 2026-03-31) — +Total Revenue: 128000.00
FGNXP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2716000.00
FGNXP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 216799000.00
FGNXP balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
FGNXP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 13395000.00
FGNXP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 16999000.00
FGNXP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 14141000.00
FGNXP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 31289000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -370000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -14427000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 21660000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -6229000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Financing Activities: 0.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Investing Activities: -250000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Operating Activities: 0.00
FGNXP cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -201000.00
FGNXP cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -1022000.00